• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA

AROVELLA THERAPEUTICS LIMITED

1.01% ! 10.0¢
Market Cap $118.8M  !

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ALA
Check out Mink Therapeutics
30/07/25 19 7.1K
30/07/25 Last post  JD258 Comments Created with Sketch.  19  Views Created with Sketch.  7.1K 
ALA 28/07/25 0 380
28/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  380 
ALA 28/07/25 0 298
28/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  298 
ALA 16/07/25 0 401
16/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  401 
ALA
ALA Investor Updates
15/07/25 36 17K
15/07/25 Last post  abitlikeme Comments Created with Sketch.  36  Views Created with Sketch.  17K 
ALA 15/07/25 11 5.0K
15/07/25 Last post  Ozibobby Comments Created with Sketch.  11  Views Created with Sketch.  5.0K 
ALA 10/07/25 7 2.6K
10/07/25 Last post  Bluebush Comments Created with Sketch.  7  Views Created with Sketch.  2.6K 
ALA 07/07/25 0 366
07/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  366 

See All Discussions arrow Created with Sketch.

Timeline

Investor Presentation
28 Jul 10:36
 
Quarterly Activities/Appendix 4C Cash Flow Report
28 Jul 10:29
 
Notification regarding unquoted securities - ALA
16 Jul 08:54
 
Notification of cessation of securities - ALA
07 Jul 08:58
 
Investor Presentation
02 Jul 09:12
 
Final Director's Interest Notice
01 Jul 11:11
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
10.0¢
Change
0.001(1.01%)
Mkt cap ! $118.8M
Open High Low Value Volume
10.0¢ 10.0¢ 10.0¢ $12.12K 121.2K

Buyers (Bids)

No. Vol. Price($)
5 168611 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 257107 3
View Market Depth
Last trade - 10.46am 31/07/2025 (20 minute delay) ?
Last
10.0¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
10.0¢ 10.0¢ 10.0¢ 61233
Last updated 10.46am 31/07/2025 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.